Orgovyx 120 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FQJQD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,542
Award facts
- Contract value 100% obligated
- $5,542.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $5,542.08 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price contract was issued on September 10, 2025, with an ultimate completion date of October 1, 2025. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare systems, fulfills this order as part of its comprehensive global pharmaceutical support mission. The company supplies a broad spectrum of pharmaceutical products and medical supplies to support Defense Health Agency operations and other federal healthcare systems. Orgovyx is a hormone therapy medication indicated for prostate cancer treatment, representing the type of specialized healthcare commodity routinely procured through the DLA's pharmaceutical supply chain. The absence of a set-aside designation indicates this award was made through open competition, consistent with AmerisourceBergen's demonstrated capability to meet federal procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FQJQD?
SPE2DB25FQJQD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 10, 2025.
How much is contract SPE2DB25FQJQD worth?
The government has obligated $5,542 on SPE2DB25FQJQD.
Is contract SPE2DB25FQJQD an order under another contract?
Yes. SPE2DB25FQJQD is a delivery order under SPE2DB25D3005, an indefinite delivery contract.
Was contract SPE2DB25FQJQD competed?
The extent of competition for SPE2DB25FQJQD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award